by Simran Chahal | Feb 25, 2018 | Health
In a study of over 800 rheumatoid arthritis (RA) patients, presented this week at the Canadian Rheumatology (CRA) Association Meeting, it was shown that a positive 14-3-3η blood test amplified the risk of rapid joint damage progression when added to current measures....
by Simran Chahal | Feb 3, 2018 | News
As a founding member, we are thrilled that the BC-led #DigitalSupercluster has been chosen. Truly an exciting day for technology innovation in Canada! Read full story
by Simran Chahal | Jan 3, 2018 | News
Augurex CEO Norma Biln was awarded Canada’s Most Powerful Women: Top 100 Award for her extraordinary leadership and continued drive to inspire others. The Top 100 Award Winner community now includes 1,005 remarkable women who together celebrate accomplishments,...
by Simran Chahal | Nov 1, 2017 | News
At the world’s premier arthritis conference, the American College of Rheumatology Annual Meeting (ACR), taking place in San Diego on November 3rd-8th, leading investigators from the United States, Canada and Egypt will present new data on the 14-3-3η blood test....
by Simran Chahal | Oct 17, 2017 | News
NEWS RELEASE | OCTOBER 17, 2017 Vancouver, BC — Augurex Life Sciences Corp is proud to announce that 14-3-3η, a novel rheumatoid arthritis (RA) biomarker, is paving a future for better patient outcomes. Today the U.S Patent and Trademark Office (USPTO) has issued...
